Latest News

Opinion: Transforming psychedelics into mainstream medicines

Research on psychedelics, which have been profoundly stigmatized, highly restricted, and tragically undeveloped for more than half a century, is stirring back to life and rekindling scientific, medical, and cultural interest in these compounds.

I’m not talking about microdosing psilocybin or other psychedelics for their anecdotal effects on productivity, focus, or creativity. What I’m referring to is a serendipitous discovery arising from this renaissance of research showing that psychedelics could someday be transformed into anti-inflammatory and antidepressant medicines devoid, at clinically relevant dose levels, of their distinctive effects on perception, cognition, mood, and more.

Read the rest…

Source link

Related posts

Breakthrough study identifies specific antibody target implicated in neuropsychiatric lupus


One in five high school seniors vaped marijuana in the last year, fueling concern among health officials


Children's Brains Benefit From Proper Conversations With Adults


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy